Beijing Tiantan - Public Comps and Valuation Multiples

Beijing Tiantan Overview

About Beijing Tiantan

Beijing Tiantan Biological Products Corp Ltd uses healthy human plasma and specifically immunized human plasma as raw materials and adopts genetic recombination technology to develop and produce blood products and engage in the blood product business. The company's main products include human albumin, human immunoglobulin (pH4) for intravenous injection, human hepatitis B immunoglobulin, human immunoglobulin, human rabies immunoglobulin, human histamine immunoglobulin, and others.

Founded

1998

HQ

Employees

5.3K+

Website

tiantanbio.com

Sectors

Biopharmaceuticals
BioTech

Financials

LTM Revenue $925M

LTM EBITDA $337M

EV

$4.5B

Valuation Multiples

Multiples.vc

Valuation Multiples for 15K+ Public Comps

Benchmark forward-looking revenue and EBITDA valuation multiples across generative AI, climate tech, semiconductors, online marketplaces, vertical SaaS and 220 more verticals.

Browse Valuation Multiples

Beijing Tiantan Financials

As of December 2025, Beijing Tiantan reported last 12-month revenue of $925M and EBITDA of $337M.

In the same period, Beijing Tiantan generated $395M in LTM gross profit and $179M in net income.

See Beijing Tiantan valuation multiples based on analyst estimates

Beijing Tiantan P&L

In the most recent fiscal year, Beijing Tiantan reported revenue of $862M and EBITDA of $412M.

Beijing Tiantan expects next 12-month revenue of XXX and NTM EBITDA of XXX

See Beijing Tiantan valuation multiples based on analyst estimates

	LTM	NTM	Last FY	FY 2026	FY 2027	FY 2028
Revenue	$925M	XXX	$862M	XXX	XXX	XXX
Gross Profit	$395M	XXX	$471M	XXX	XXX	XXX
Gross Margin	43%	XXX	55%	XXX	XXX	XXX
EBITDA	$337M	XXX	$412M	XXX	XXX	XXX
EBITDA Margin	36%	XXX	48%	XXX	XXX	XXX
EBIT	$290M	XXX	$360M	XXX	XXX	XXX
EBIT Margin	31%	XXX	42%	XXX	XXX	XXX
Net Profit	$179M	XXX	$221M	XXX	XXX	XXX
Net Margin	19%	XXX	26%	XXX	XXX	XXX
Net Debt	XXX	XXX	n/a	XXX	XXX	XXX

Financial data powered by Morningstar, Inc.

.seo-only-financials-wrapper { position: static; left: auto; width: auto; height: auto; overflow: visible; }

Financial performance metrics for Beijing Tiantan including revenue, profitability, and margin analysis across different time periods. The company reported last twelve months revenue of $925M. EBITDA for the last twelve months was $337M. In the most recent fiscal year, Beijing Tiantan achieved $862M in revenue and $412M in EBITDA.
Financial Metric	Last Twelve Months (LTM)	Next Twelve Months (NTM)	Most Recent Fiscal Year	Current Fiscal Year (2026)	Next Fiscal Year (2027)	Two Years Forward (2028)
Total Revenue	$925M	Analyst estimates available to subscribers	$862M	Analyst estimates available to subscribers	Analyst estimates available to subscribers	Analyst estimates available to subscribers
Gross Profit	$395M	Analyst estimates available to subscribers	$471M	Analyst estimates available to subscribers	Analyst estimates available to subscribers	Analyst estimates available to subscribers
Gross Profit Margin	42.7% gross margin	Analyst estimates available to subscribers	54.7% gross profit margin	Analyst estimates available to subscribers	Analyst estimates available to subscribers	Analyst estimates available to subscribers
EBITDA (Earnings Before Interest, Taxes, Depreciation, Amortization)	$337M	Analyst estimates available to subscribers	$412M	Analyst estimates available to subscribers	Analyst estimates available to subscribers	Analyst estimates available to subscribers
EBITDA Margin	36.5% EBITDA margin	Analyst estimates available to subscribers	47.8% EBITDA margin	Analyst estimates available to subscribers	Analyst estimates available to subscribers	Analyst estimates available to subscribers
EBIT (Earnings Before Interest and Taxes)	$290M	Analyst estimates available to subscribers	$360M	Analyst estimates available to subscribers	Analyst estimates available to subscribers	Analyst estimates available to subscribers
EBIT Margin	31.3% EBIT margin	Analyst estimates available to subscribers	41.8% EBIT margin	Analyst estimates available to subscribers	Analyst estimates available to subscribers	Analyst estimates available to subscribers
Net Income (Net Profit)	$179M	Analyst estimates available to subscribers	$221M	Analyst estimates available to subscribers	Analyst estimates available to subscribers	Analyst estimates available to subscribers
Net Profit Margin	19.4% net profit margin	Analyst estimates available to subscribers	25.7% net profit margin	Analyst estimates available to subscribers	Analyst estimates available to subscribers	Analyst estimates available to subscribers
Net Debt Position	Detailed debt information available to subscribers	Detailed debt information available to subscribers	n/a	Detailed debt information available to subscribers	Detailed debt information available to subscribers	Detailed debt information available to subscribers

Financial Performance Summary for Beijing Tiantan

This financial data table provides comprehensive performance metrics for Beijing Tiantan, a company based in China. The metrics include revenue, profitability measures, and operational efficiency indicators across multiple time periods.

Recent Performance Highlights

Beijing Tiantan generated $925M in revenue over the last twelve months.
The company achieved $337M in EBITDA over the last twelve months.
Gross profit for the last twelve months was $395M.
Net income over the last twelve months reached $179M.

Fiscal Year Performance

In the most recent fiscal year, Beijing Tiantan reported $862M in total revenue.
Fiscal year EBITDA was $412M.
The company maintained a gross profit margin of 54.7% in the most recent fiscal year.
EBITDA margin for the fiscal year was 47.8%.
Net profit margin reached 25.7% in the most recent fiscal year.

This financial data is sourced from Morningstar, Inc. and represents the most recent available information for Beijing Tiantan. Forward-looking estimates and detailed financial projections are available through our premium subscription service.

Beijing Tiantan Stock Performance

Beijing Tiantan has current market cap of CNY 33.3B (or $4.8B), and EV of CNY 31.7B (or $4.5B).

Market Cap Evolution

Beijing Tiantan Stock Data

As of January 16, 2026, Beijing Tiantan's stock price is CNY 17 (or $2).

See Beijing Tiantan trading valuation data

EV	Market Cap	Price 1D	Price 1M	Price 3M	Price 12M	EPS
$4.5B	$4.8B	XXX	XXX	XXX	XXX	$0.09

Benchmark Trading Valuation Multiples by Industry

Sign up to access valuation multiples like growth-adjusted P/E, next 12-month EV/Revenue, EBITDA multiples by industry and many more

Start Free Trial

Beijing Tiantan Valuation Multiples

Beijing Tiantan's trades at 4.9x EV/Revenue multiple, and 13.4x EV/EBITDA.

See valuation multiples for Beijing Tiantan and 15K+ public comps

Beijing Tiantan Financial Valuation Multiples

As of January 16, 2026, Beijing Tiantan has market cap of $4.8B and EV of $4.5B.

Equity research analysts estimate Beijing Tiantan's 2025E EV/Revenue multiple at XXX and 2025E EV/EBITDA multiple at XXX

Beijing Tiantan has a P/E ratio of 26.6x.

	LTM	NTM	Last FY	FY 2026	FY 2027	FY 2028
Market cap (current)	$4.8B	XXX	$4.8B	XXX	XXX	XXX
EV (current)	$4.5B	XXX	$4.5B	XXX	XXX	XXX
EV/Revenue	4.9x	XXX	4.9x	XXX	XXX	XXX
EV/EBITDA	13.4x	XXX	13.4x	XXX	XXX	XXX
EV/EBIT	15.6x	XXX	15.6x	XXX	XXX	XXX
EV/Gross Profit	11.4x	XXX	n/a	XXX	XXX	XXX
P/E	26.6x	XXX	26.6x	XXX	XXX	XXX
EV/FCF	n/a	XXX	-127.8x	XXX	XXX	XXX

Valuation data powered by FactSet, Inc. and Morningstar, Inc.

Get Beijing Tiantan Valuation Multiples

Access all public comps and forward-looking valuation multiples like EV/Revenue in 2025, based on equity research analyst estimates.

Start Free Trial

Beijing Tiantan Margins & Growth Rates

Beijing Tiantan's last 12 month revenue growth is 9%

Beijing Tiantan's revenue per employee in the last FY averaged $0.2M, while opex per employee averaged $21K for the same period.

Beijing Tiantan's rule of 40 is 49% (metric relevant for SaaS companies only, counted as combined revenue growth rate and EBITDA margin).

Beijing Tiantan's rule of X is 60% (created by Bessemer, rule of X is another metric relevant for SaaS companies only, ~1.5x stronger vs. the traditional Rule of 40, counted as revenue growth rate multiplied by 2.5 plus EBITDA margin).

See operational valuation multiples for Beijing Tiantan and other 15K+ public comps

Beijing Tiantan Operational Valuation Multiples

	LTM	NTM	Last FY	FY 2026	FY 2027	FY 2028
Revenue Growth	9%	XXX	12%	XXX	XXX	XXX
EBITDA Margin	36%	XXX	36%	XXX	XXX	XXX
EBITDA Growth	16%	XXX	7%	XXX	XXX	XXX
Rule of 40	49%	XXX	46%	XXX	XXX	XXX
Bessemer Rule of X	XXX	XXX	60%	XXX	XXX	XXX
Revenue per Employee	XXX	XXX	$0.2M	XXX	XXX	XXX
Opex per Employee	XXX	XXX	$21K	XXX	XXX	XXX
S&M Expenses to Revenue	XXX	XXX	0%	XXX	XXX	XXX
G&A Expenses to Revenue	XXX	XXX	n/a	XXX	XXX	XXX
R&D Expenses to Revenue	XXX	XXX	2%	XXX	XXX	XXX
Opex to Revenue	XXX	XXX	13%	XXX	XXX	XXX

Valuation data powered by FactSet, Inc. and Morningstar, Inc.

Valuation Multiples Across 220+ Verticals

Benchmark public comps and private revenue and EBITDA valuation multiples across GRC software, cloud infrastructure, DevOps, online marketplaces and so much more!

Digital Therapeutics

Pharma Analytics

Private Equity

ERP Software

Developer Tools

Consumer SaaS

Streaming Platforms

Explore Valuation Multiples by Industry

Start Free Trial